Ceridian HCM’s (CDAY) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Ceridian HCM (NYSE:CDAY) in a report issued on Monday morning, AnalystRatings.com reports. Needham & Company LLC currently has a $60.00 target price on the stock, down from their previous target price of $80.00.

A number of other equities analysts have also issued reports on the company. CIBC initiated coverage on Ceridian HCM in a report on Thursday, March 5th. They set an outperformer rating and a $84.00 price target on the stock. Royal Bank of Canada initiated coverage on Ceridian HCM in a report on Tuesday, December 3rd. They set an outperform rating and a $71.00 price target on the stock. Barclays reissued a hold rating and set a $52.00 price target on shares of Ceridian HCM in a report on Tuesday, March 17th. Cowen reissued a buy rating and set a $85.00 price target on shares of Ceridian HCM in a report on Thursday, February 6th. Finally, ValuEngine raised Ceridian HCM from a sell rating to a hold rating in a report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the company. The company currently has a consensus rating of Buy and an average price target of $68.65.

NYSE CDAY opened at $52.24 on Monday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.37. Ceridian HCM has a 52-week low of $38.40 and a 52-week high of $79.11. The business’s 50-day moving average price is $64.07 and its 200 day moving average price is $60.22. The firm has a market cap of $7.17 billion, a P/E ratio of 98.57 and a beta of 1.45.

Ceridian HCM (NYSE:CDAY) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.07 by $0.01. Ceridian HCM had a return on equity of 1.73% and a net margin of 9.55%. The firm had revenue of $221.80 million for the quarter, compared to analyst estimates of $221.15 million. During the same quarter last year, the company posted $0.07 earnings per share. The business’s revenue was up 10.7% on a year-over-year basis. As a group, analysts anticipate that Ceridian HCM will post 0.25 earnings per share for the current year.

In other news, EVP Lisa M. Sterling sold 15,058 shares of Ceridian HCM stock in a transaction that occurred on Wednesday, January 8th. The shares were sold at an average price of $70.21, for a total transaction of $1,057,222.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Arthur Gitajn sold 86,500 shares of Ceridian HCM stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $76.07, for a total transaction of $6,580,055.00. Following the sale, the chief financial officer now owns 98,127 shares of the company’s stock, valued at $7,464,520.89. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,001,558 shares of company stock valued at $291,362,277. 26.90% of the stock is owned by insiders.

Several hedge funds have recently bought and sold shares of CDAY. First Mercantile Trust Co. acquired a new stake in shares of Ceridian HCM during the 4th quarter valued at approximately $97,000. Dupont Capital Management Corp acquired a new stake in shares of Ceridian HCM during the 4th quarter valued at approximately $167,000. Metropolitan Life Insurance Co NY lifted its position in shares of Ceridian HCM by 35.4% during the 1st quarter. Metropolitan Life Insurance Co NY now owns 3,655 shares of the company’s stock valued at $187,000 after acquiring an additional 955 shares during the period. Advisor Group Inc. lifted its position in shares of Ceridian HCM by 34.7% during the 4th quarter. Advisor Group Inc. now owns 3,089 shares of the company’s stock valued at $209,000 after acquiring an additional 795 shares during the period. Finally, Bullseye Asset Management LLC acquired a new stake in shares of Ceridian HCM during the 4th quarter valued at approximately $227,000. Institutional investors own 89.03% of the company’s stock.

About Ceridian HCM

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Further Reading: Buy Rating

Analyst Recommendations for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.